Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation

Todd E. Williams, Charles Thomas, Andrew T. Turrisi

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The treatment of non-small cell lung cancer has continued to evolve with the advent of improved staging technologies, chemotherapeutic agents, and methods of radiation delivery. Treatment of clinically uninvolved, regional lymph nodes historically has been delivered in the attempt to cover unseen disease, reduce regional failure, and improve survival. None of these suppositions has been tested nor are they supported by data. With enhanced staging using modalities like positron emission tomography and esophageal ultrasonography, treatment portals can be designed to encompass known disease with greater accuracy and confidence. Data for early-stage non-small cell lung cancer is now increasing and strongly suggest that eliminating elective nodal irradiation does not result in a high incidence of nodal relapse and does not compromise survival. Three-dimensional conformal radiotherapy incorporates better targeting and beam directions to effect smaller treatment volumes that include only clinically evident disease. It provides treatment techniques that maximize tumor dose and minimize normal tissue toxicity. Using smaller fields that do not incorporate elective nodal regions may allow higher doses, and these may help improve local control and survival in a disease where current results are unacceptable. Copyright (C) 2000 by W.B. Saunders Company.

Original languageEnglish (US)
Pages (from-to)315-323
Number of pages9
JournalSeminars in Radiation Oncology
Volume10
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
lungs
cancer
Radiation
irradiation
radiation
Conformal Radiotherapy
Therapeutics
dosage
lymphatic system
toxicity
Positron-Emission Tomography
confidence
radiation therapy
positrons
Ultrasonography
delivery
drugs
tumors
incidence

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Radiation

Cite this

Counterpoint : Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. / Williams, Todd E.; Thomas, Charles; Turrisi, Andrew T.

In: Seminars in Radiation Oncology, Vol. 10, No. 4, 2000, p. 315-323.

Research output: Contribution to journalArticle

@article{e03ee70a594f4a528c7b214ea59ddcdd,
title = "Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation",
abstract = "The treatment of non-small cell lung cancer has continued to evolve with the advent of improved staging technologies, chemotherapeutic agents, and methods of radiation delivery. Treatment of clinically uninvolved, regional lymph nodes historically has been delivered in the attempt to cover unseen disease, reduce regional failure, and improve survival. None of these suppositions has been tested nor are they supported by data. With enhanced staging using modalities like positron emission tomography and esophageal ultrasonography, treatment portals can be designed to encompass known disease with greater accuracy and confidence. Data for early-stage non-small cell lung cancer is now increasing and strongly suggest that eliminating elective nodal irradiation does not result in a high incidence of nodal relapse and does not compromise survival. Three-dimensional conformal radiotherapy incorporates better targeting and beam directions to effect smaller treatment volumes that include only clinically evident disease. It provides treatment techniques that maximize tumor dose and minimize normal tissue toxicity. Using smaller fields that do not incorporate elective nodal regions may allow higher doses, and these may help improve local control and survival in a disease where current results are unacceptable. Copyright (C) 2000 by W.B. Saunders Company.",
author = "Williams, {Todd E.} and Charles Thomas and Turrisi, {Andrew T.}",
year = "2000",
language = "English (US)",
volume = "10",
pages = "315--323",
journal = "Seminars in Radiation Oncology",
issn = "1053-4296",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Counterpoint

T2 - Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation

AU - Williams, Todd E.

AU - Thomas, Charles

AU - Turrisi, Andrew T.

PY - 2000

Y1 - 2000

N2 - The treatment of non-small cell lung cancer has continued to evolve with the advent of improved staging technologies, chemotherapeutic agents, and methods of radiation delivery. Treatment of clinically uninvolved, regional lymph nodes historically has been delivered in the attempt to cover unseen disease, reduce regional failure, and improve survival. None of these suppositions has been tested nor are they supported by data. With enhanced staging using modalities like positron emission tomography and esophageal ultrasonography, treatment portals can be designed to encompass known disease with greater accuracy and confidence. Data for early-stage non-small cell lung cancer is now increasing and strongly suggest that eliminating elective nodal irradiation does not result in a high incidence of nodal relapse and does not compromise survival. Three-dimensional conformal radiotherapy incorporates better targeting and beam directions to effect smaller treatment volumes that include only clinically evident disease. It provides treatment techniques that maximize tumor dose and minimize normal tissue toxicity. Using smaller fields that do not incorporate elective nodal regions may allow higher doses, and these may help improve local control and survival in a disease where current results are unacceptable. Copyright (C) 2000 by W.B. Saunders Company.

AB - The treatment of non-small cell lung cancer has continued to evolve with the advent of improved staging technologies, chemotherapeutic agents, and methods of radiation delivery. Treatment of clinically uninvolved, regional lymph nodes historically has been delivered in the attempt to cover unseen disease, reduce regional failure, and improve survival. None of these suppositions has been tested nor are they supported by data. With enhanced staging using modalities like positron emission tomography and esophageal ultrasonography, treatment portals can be designed to encompass known disease with greater accuracy and confidence. Data for early-stage non-small cell lung cancer is now increasing and strongly suggest that eliminating elective nodal irradiation does not result in a high incidence of nodal relapse and does not compromise survival. Three-dimensional conformal radiotherapy incorporates better targeting and beam directions to effect smaller treatment volumes that include only clinically evident disease. It provides treatment techniques that maximize tumor dose and minimize normal tissue toxicity. Using smaller fields that do not incorporate elective nodal regions may allow higher doses, and these may help improve local control and survival in a disease where current results are unacceptable. Copyright (C) 2000 by W.B. Saunders Company.

UR - http://www.scopus.com/inward/record.url?scp=0033784888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033784888&partnerID=8YFLogxK

M3 - Article

C2 - 11040332

AN - SCOPUS:0033784888

VL - 10

SP - 315

EP - 323

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

SN - 1053-4296

IS - 4

ER -